{"url":"https://lda.senate.gov/api/v1/filings/1d2efac6-8129-45f2-b20f-e87422b6aae1/","filing_uuid":"1d2efac6-8129-45f2-b20f-e87422b6aae1","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2015,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/1d2efac6-8129-45f2-b20f-e87422b6aae1/print/","filing_document_content_type":"text/html","income":"60000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Tracy Spicer","dt_posted":"2015-04-20T15:12:19.017000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"401 9th St. NW","registrant_address_2":"Suite 720","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":72111,"url":"https://lda.senate.gov/api/v1/registrants/72111/","house_registrant_id":35940,"name":"AVENUE SOLUTIONS","description":"Government representation","address_1":"401 9th St. NW","address_2":"Suite 720","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"AMY TEJRAL","contact_telephone":"+1 202-347-9848","dt_updated":"2026-01-30T17:55:20.768017-05:00"},"client":{"id":165794,"url":"https://lda.senate.gov/api/v1/clients/165794/","client_id":1004188,"name":"RICHIE'S SPECIALTY PHARMACY","general_description":"compounding pharmacy","client_government_entity":false,"client_self_select":false,"state":"TX","state_display":"Texas","country":"US","country_display":"United States of America","ppb_state":null,"ppb_state_display":null,"ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2013-02-11"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"discussions on compounding issues;\nPL 113-54, Pharmaceutical Quality, Security & Accountability Act;\nTRICARE coverage of compounded medications prepared from bulk chemicals at Department of Defense, Veterans Affairs and TRICARE","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":48260,"prefix":"ms","prefix_display":"MS.","first_name":"ELIZABETH","nickname":null,"middle_name":"MACDONALD","last_name":"BARNETT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":23462,"prefix":null,"prefix_display":null,"first_name":"TRACY","nickname":null,"middle_name":null,"last_name":"SPICER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":10838,"prefix":null,"prefix_display":null,"first_name":"AMY","nickname":null,"middle_name":null,"last_name":"TEJRAL","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}